Decreased Striatal RGS2 Expression Is Neuroprotective in Huntington's Disease (HD) and Exemplifies a Compensatory Aspect of HD-Induced Gene Regulation
2011
RGS2 Downregulation Is Protective in Huntington's Disease
Sample size: 15
publication
10 minutes
Evidence: moderate
Author Information
Author(s): Seredenina, Tamara Gokce, Ozgun Luthi-Carter, Ruth Luthi-Carter
Primary Institution: Ecole Polytechnique Fédérale de Lausanne (EPFL)
Hypothesis
Can downregulation of specific genes mitigate neurotoxicity in Huntington's disease?
Conclusion
Decreased expression of RGS2 and RASD2 is neuroprotective in Huntington's disease neurons.
Supporting Evidence
- RGS2 downregulation enhances ERK activation, which is linked to neuroprotection.
- Silencing RGS2 or RASD2 improved neuronal survival in Huntington's disease models.
- Restoring RGS2 expression increased neurotoxicity in striatal neurons.
Takeaway
This study found that lowering the levels of certain genes can help protect brain cells in Huntington's disease.
Methodology
The study used lentiviral vectors to manipulate gene expression in primary striatal neurons and assessed neuroprotection through cell viability assays.
Limitations
The study primarily focused on in vitro models, which may not fully replicate in vivo conditions.
Statistical Information
P-Value
6.81E-05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website